Seelos Therapeutics Stock News

GAINERS: Small Pharma (OTC: Full story available on Benzinga.com

GAINERS: Small Pharma (OTC: DMTTF ) shares closed up 14.55% at $0.21 GH Research (NASDAQ: GHRS ) shares closed up 3.35% at $16.99 Field Trip Health (NASDAQ: FTRP ) shares closed up 2.00% at $2.04 LOSERS: Mindset Pharma (OTC: MSSTF ) shares closed down -4.33% at $0.57 Seelos Therapeutics (NASDAQ: SEEL ) shares closed down Full story available on Benzinga.com

Brokerages forecast that Seelos Therapeutics, Inc. (NASDAQ:SEEL) will report earnings per share of ($0.12) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Seelos Therapeutics earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.12). Seelos Therapeutics posted earnings per share of ($0.13) during the same []

Seelos received communication from the FDA that its part 2 study will be considered registrational. This derisks the company considerably, although the only efficacy data we have so far is from an ope

NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that it has granted

Brokerages expect Seelos Therapeutics, Inc. (NASDAQ:SEEL) to report earnings per share (EPS) of ($0.12) for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Seelos Therapeutics earnings. The lowest EPS estimate is ($0.12) and the highest is ($0.11). Seelos Therapeutics reported earnings of ($0.13) per share during the same quarter []

Seelos Therapeutics, Inc. (NASDAQ:SEEL) with the stream of 1.23% also noticed, India Regis Corporation (NYSE:RGS) encountered a rapid change of -2.46% in the last hour of Fridays trading session. Seelos The post Undertaking Stock: Seelos Therapeutics, Inc. (NASDAQ:SEEL), Regis Corporation (NYSE:RGS) appeared first on Stocks Equity .

The stock price of Seelos Therapeutics Inc (NASDAQ: SEEL) fell by 6.47% today. This is why it happened.

The trading price of Seelos Therapeutics Inc. (NASDAQ:SEEL) closed lower on Monday, December 13, closing at $1.70, -1.73% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

The usage of psychedelics like psilocybin, LSD, ketamine, and others are becoming more mainstream, especially with the initial steps to legalization getting moving across a number of states in the U.S

Seelos Therapeutics, Inc. (SEEL) with the stream of -5.75% also noticed, India Allied Healthcare Products, Inc. (AHPI) encountered a rapid change of -11.82% in the last hour of Fridays trading The post Have an eye on: Seelos Therapeutics, Inc. (NASDAQ:SEEL), Allied Healthcare Products, Inc. (NASDAQ:AHPI) appeared first on Stocks Equity .

Wall Street brokerages expect Seelos Therapeutics, Inc. (NASDAQ:SEEL) to post ($0.12) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have issued estimates for Seelos Therapeutics earnings, with estimates ranging from ($0.12) to ($0.11). Seelos Therapeutics reported earnings per share of ($0.13) in the same quarter last year, which suggests a positive []

IX BIOPHARMA LTD. ( SGX:42C ) iX Biopharma - Just A Warm Up iX Biopharma (SGX:42C) signs out-licensing agreement for its Wafermine drug worth more than S$300mil (excluding royalties) with Nasdaq-listed Seelos Therapeutics . Seelos provides the regulatory, clinical development and local USA market knowledge to register and commercialise Wafermine and other ketamine-related products. Seelos will fund future development, manufacturing and commercialisation of Wafermine and related drugs. iX Biopharma will receive an upfront payment, development milestone, sales milestone and royalties. Continue Reading »